What Happened?
Shares of hospital operator HCA Healthcare (NYSE: HCA) fell 8.7% in the afternoon session after the company reported first-quarter 2026 results where a key profitability metric, adjusted EBITDA, missed analyst expectations, overshadowing revenue and earnings per share that were in line with forecasts.
The company reported revenue of $19.11 billion and adjusted earnings of $7.15 per share, both meeting Wall Street's consensus estimates. However, its adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), a measure of operational profitability, came in at $3.8 billion, slightly below the anticipated $3.85 billion.
This miss appeared to disappoint investors, who were likely looking for stronger performance across the board. While other metrics, such as the company's operating margin, showed significant year-over-year improvement, the shortfall in EBITDA was enough to send the stock lower in the morning session.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy HCA Healthcare? Access our full analysis report here, it’s free.
What Is The Market Telling Us
HCA Healthcare’s shares are not very volatile and have only had 2 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 3 months ago when the stock gained 11% on the news that the company's upbeat profit forecast for 2026 overshadowed a miss on fourth-quarter revenue.
The company reported fourth-quarter earnings of $8.14 per share, beating analyst estimates by 9.2%. However, revenue for the quarter was $19.51 billion, slightly missing Wall Street's expectations. Looking ahead, investors focused on the stronger-than-expected guidance for 2026. HCA projected full-year earnings per share with a midpoint of $30.30 and EBITDA with a midpoint of $16 billion, both surpassing consensus estimates.
This positive profit outlook offset the company's full-year revenue guidance, which came in slightly below analyst forecasts, suggesting investors are confident in HCA's ability to manage costs and drive profitability.
HCA Healthcare is down 7.9% since the beginning of the year, and at $433.12 per share, it is trading 20.5% below its 52-week high of $545.13 from March 2026. Despite the year-to-date decline, investors who bought $1,000 worth of HCA Healthcare’s shares 5 years ago would now be looking at an investment worth $2,160.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
